Stay updated on Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma

Sign up to get notified when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a Locations section with Henan (Zhengzhou, Henan, China) and related location details. Removed the Henan Locations entry and the HHS Vulnerability Disclosure link, and updated the revision tag to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T11:57:32.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0. No substantive changes to the study details or page content are evident.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:33.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removed the government funding status notice that warned information might not be up to date due to appropriations, which previously informed users about potential delays or unresponsiveness of the NIH Clinical Center. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:25:15.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The new screenshot shows the same study details (PD-1 pembrolizumab in relapsed/refractory NK/T cell lymphoma) with only minor layout and labeling differences; there are no changes to core content such as enrollment, primary outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:22:45.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Major addition of a government funding notice and upgrade to v3.2.0, replacing v3.1.0; references to operating status and status inquiries are now present.
    Difference
    5%
    Check dated 2025-10-06T05:59:34.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Updated terminology and versioning: standardizes the condition name to NK/T cell lymphoma and updates the page from v3.0.2 to v3.1.0, plus addition of contact-like identifiers.
    Difference
    0.4%
    Check dated 2025-09-29T03:13:54.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.